These substances interact with specific hormonal pathways to alter gene expression and cellular behavior. Anabolic steroids enhance muscle hypertrophy and recovery by accelerating metabolic pathways tied to tissue regeneration. However, they can also disrupt natural hormone production, particularly affecting growth plate activity in adolescents. Corticosteroids suppress inflammatory cytokines, effectively managing chronic inflammation but potentially weakening connective tissue over prolonged use. Understanding how steroids work in the body requires examining their role as synthetic hormones within complex biochemical networks, where they either amplify or suppress native hormone signals to produce targeted physiological effects.
What Are Steroids?
Steroids are a type of organic compound that have a characteristic structure of four rings of carbon atoms. They are found naturally in the body and are involved in a variety of physiological processes, including the regulation of metabolism, inflammation, immune function, and the development of sexual characteristics.
Corticosteroids and anabolic steroids are the two primary categories of steroids. Corticosteroids are synthetic versions of the natural hormone cortisol, which is produced by the adrenal glands. They are often used to treat inflammation and immune system disorders, such as asthma, arthritis, and allergies.
Contrarily, anabolic steroids are synthetic forms of the male hormone testosterone. They are often used by athletes and bodybuilders to increase muscle mass, strength, and performance. However, they can also have serious side effects and health risks, especially when used improperly or in excessive amounts. That is why the use of anabolic steroids is illegal in most countries, and their use should only be under the supervision of a qualified medical professional.
Do Anabolic Steroids Affect Height Growth?
Anabolic steroids can disrupt normal height development, especially during adolescence, by accelerating the closure of epiphyseal growth plates. These growth plates—soft, cartilaginous areas at the ends of long bones—are responsible for linear bone growth. When exposed to elevated hormone levels, particularly androgens and estrogens, they can close prematurely. This condition, known as epiphyseal closure, halts further height increase regardless of genetic potential. The conversion of excess testosterone into estrogen through a process called aromatization plays a central role in this early plate fusion, especially during the critical phase of the adolescent growth spurt. Clinical evidence summarized in pediatric medical literature confirms that adolescents in early puberty who use anabolic steroids face a real risk of premature epiphyseal closure, resulting in shorter adult stature than would otherwise be predicted.
Additionally, anabolic steroid use disrupts the body's hormone feedback loop, leading to suppressed endogenous testosterone production and altered growth hormone signaling. These disruptions hinder the body's ability to regulate hormones essential for normal skeletal development. When external anabolic steroids enter the system, they downregulate the hypothalamic-pituitary-gonadal (HPG) axis, reducing natural testosterone levels and distorting hormonal balance. This imbalance can delay or distort the timing of puberty and skeletal maturation. While some assume that anabolic steroids might increase height due to their growth-promoting effects on muscle, the hormonal interference they cause produces the opposite result — a net loss in final adult height. This is particularly critical in teens, where hormonal precision is vital for optimal physical development.
How Corticosteroids Affect Childhood Growth
Corticosteroids, particularly prednisone and dexamethasone, are commonly prescribed in pediatric care to manage chronic conditions such as asthma and autoimmune diseases. While effective in reducing inflammation and suppressing the immune response, their prolonged use raises significant concerns regarding pediatric growth. Multiple clinical studies confirm that long-term systemic corticosteroid therapy can impair height velocity in children. The underlying mechanism involves disruption of the hypothalamic-pituitary-adrenal (HPA) axis, leading to reduced secretion of growth hormone and catabolic effects on bone and muscle tissue.
Inhaled corticosteroids, the standard treatment for persistent childhood asthma, present a more nuanced risk profile. A systematic review and meta-analysis published in PLOS ONE (Loke et al., 2015) reviewed 23 studies and found that ICS use significantly reduced growth velocity at one-year follow-up by an average of 0.48 cm/year, with a measurable but modest reduction of about 1.2 cm in final adult height in a high-quality RCT comparing budesonide to placebo. The impact varies by drug type, dosage, and treatment duration, with budesonide showing greater growth suppression compared to fluticasone. Additionally, corticosteroids can negatively affect bone density, further compounding risks to skeletal development. Clinicians must balance disease control with the long-term side effects of steroids in children, tailoring therapy to minimize exposure while ensuring effective management of chronic inflammation. Parents should be informed about potential growth impacts and monitored through growth charts and bone scans during long-term medication regimens.
Legal vs. Illegal Steroid Use for Growth
Steroids and growth hormone therapies are often confused in public discourse, but their legal and medical contexts differ sharply. Prescription-based treatments, such as growth hormone therapy, are medically approved for children and adolescents with diagnosed growth hormone deficiencies. Administered under the supervision of an endocrinologist, these therapies are legally sanctioned and monitored to minimize risks. In contrast, off-label steroid use—where anabolic steroids are used without medical justification to attempt height enhancement—falls outside legal and ethical medical practice. This type of prescription abuse is not only illegal but also potentially harmful, especially when individuals self-medicate or purchase online steroids without medical oversight.
Many people, particularly adolescents and young adults, are misled by height enhancement myths promoted by unregulated sources. These often include "height pills" or black-market steroids falsely advertised as growth boosters. However, anabolic steroids are primarily designed to increase muscle mass, not stature. Unlike growth hormone, they do not stimulate the growth plates in adolescents — and in fact tend to do the opposite by accelerating plate closure. Illegally obtained substances carry high risks of endocrine disruption, stunted growth, and long-term hormonal imbalances. Moreover, in sports and fitness circles, bodybuilders and those involved in athletic doping sometimes misuse steroids, further blurring public understanding of their purpose and legality. According to the World Anti-Doping Agency (WADA), unsupervised steroid use for performance or growth is a clear violation of medical and legal standards.
Growth Hormone Therapy vs. Steroids
Growth hormone (GH) therapy, specifically using biosynthetic somatropin, is an FDA-approved treatment for children with GH deficiency and other growth-related disorders. Administered through GH injections, this therapy stimulates the liver to produce insulin-like growth factor 1 (IGF-1), which directly promotes stature improvement by accelerating bone growth at the epiphyseal plates. Pediatric endocrinology guidelines consistently show that GH therapy, when started early and monitored closely, can produce meaningful height gains over the course of treatment. This therapeutic hormone use is regulated, evidence-based, and tailored to individual growth potential — factors critical for safe and effective outcomes.
In contrast, anabolic steroids—often misused for muscle mass—do not enhance linear growth. Steroids may even prematurely close growth plates, especially in adolescents, leading to reduced final height. Unlike GH therapy, anabolic steroids are not indicated for height enhancement and lack support from the pediatric endocrinology community. No clinical trials validate their effectiveness for increasing stature, and their use for this purpose is medically inappropriate and potentially harmful. When comparing GH vs. steroids for height, the data is clear: only HGH therapy (under medical supervision) shows verified, measurable height benefits in children with diagnosed growth disorders.
Myths and Misconceptions About Steroids and Height
Steroids do not increase height and often stunt growth when misused during adolescence. Despite widespread myths on TikTok, bodybuilding forums, and clickbait health blogs, scientific consensus confirms that anabolic steroids—when taken during puberty—can prematurely close growth plates (epiphyseal plates) in bones, leading to reduced adult height. The misconception that substances like testosterone or human growth hormone (HGH) can increase height after puberty persists largely due to pseudoscientific internet health claims and false marketing targeting teen bodybuilding communities. Peer-reviewed pediatric endocrinology literature consistently shows that while testosterone plays a role in normal growth, exogenous steroids disrupt the hormonal balance required for natural development.
Most online claims about steroids boosting height fall under pseudoscience or deliberate misinformation. Social media trends amplify myths, such as "height hacks" involving hormone injections or supplement regimens, without any scientific backing. These misleading narratives often thrive in algorithm-driven environments like TikTok, where virality outweighs accuracy. Teenagers, especially those involved in fitness subcultures, are most vulnerable to these internet height tips. However, research published in the Annals of Pediatric Endocrinology & Metabolism (Kim et al.) confirms that once growth plates close — typically between ages 16–18 in females and 18–21 in males — no supplement or steroid can increase height. The perpetuation of these urban legends not only misguides youth but also encourages dangerous experimentation with unregulated substances. Accurate information rooted in medical research is critical to debunking these myths and safeguarding adolescent health.
What Doctors Say About Steroids and Height
Medical experts and scientific consensus agree that prolonged or inappropriate use of corticosteroids in children can negatively affect growth. According to peer-reviewed research, systemic corticosteroids—especially when administered over extended periods—can impair linear growth by suppressing the hypothalamic-pituitary-adrenal (HPA) axis. Pediatricians and endocrinologists consistently warn against unsupervised steroid use, citing conclusive clinical evidence that links chronic corticosteroid exposure to growth stunting in adolescents. Both the American Academy of Pediatrics (AAP) and the Endocrine Society recommend careful dosing protocols and regular height monitoring when steroids are medically necessary.
Scientific institutions such as the Mayo Clinic and the National Institutes of Health echo this medical stance. They emphasize that while inhaled corticosteroids used for conditions like asthma carry a lower risk, even these require pediatric supervision. The Loke et al. meta-analysis in PLOS ONE found that long-term ICS use was associated with about a 1.2 cm reduction in final adult height — a small but real effect that pediatricians weigh carefully against the substantial benefits of asthma control. Physician advice across the board underscores that the clinical view on height growth must factor in steroid duration, dosage, and timing during developmental windows. This expert opinion is rooted in decades of endocrine data, health policy reviews, and international pediatric guidelines, forming a unified, science-backed position.
References
- Hong, A. R., & Kim, S. W. (2018). Corticosteroids. StatPearls, National Library of Medicine.
- Yatham, S., & Sivakumar, M. (2024). Anabolic steroids. Case Based Pediatrics for Medical Students and Residents, University of Hawaii.
- Loke, Y. K., Blanco, P., Thavarajah, M., & Wilson, A. M. (2015). Impact of inhaled corticosteroids on growth in children with asthma: A systematic review and meta-analysis. PLOS ONE.
- Kim, S. H., et al. (2015). Pubertal growth and epiphyseal fusion. Annals of Pediatric Endocrinology & Metabolism.
- National Institute on Drug Abuse. Anabolic steroids – DrugFacts. National Institutes of Health.
